Interestingly, our recent observations have suggested that AR activity in bladder cancer cells correlates with sensitivity to other conventional non-surgical treatments, such as intravesical BCG immunotherapy [12] and radiotherapy [13]. The gene discussed is AR; the disease is urinary bladder cancer.